Future studies will be important to determine whether tau might be involved in the TTP-PARN interaction resulting in the regulation of PARN activity and to test whether the appearance of pathological forms of tau and the progression of AD affects this regulation. The gene discussed is MAPT; the disease is Alzheimer disease.